PHARMAC swapping epilepsy drugs 'cannot be discounted' as a cause of deaths — neurologist

4 March 2021 - An Auckland paediatric neurologist says PHARMAC's decision to switch to a generic version of an epilepsy drug ...

Read more →

The PHARMAC non-review?

4 March 2021 - The recently announced PHARMAC review is fatally flawed.  ...

Read more →

Cancer patient told palliative care only option after being rejected PHARMAC funding

2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...

Read more →

PHARMAC ripe for reassessment

3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...

Read more →

Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise

2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...

Read more →

Review asks how Government can get the new drugs it wants funded

2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...

Read more →

Proposal to fully fund Mercilon 28 for oral contraception

26 February 2021 - PHARMAC is seeking feedback on a proposal to increase the subsidy to fully fund ethinyloestradiol 20 ...

Read more →

New Zealand Pharmaceutical Schedule - 1 March 2021

1 March 2021 - The March 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Multiple sclerosis treatments

25 February 2021 - From 1 March 2021, more people will be able to access multiple sclerosis treatments for longer. ...

Read more →

PHARMAC knew of epilepsy drug change risks - inquest

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their ...

Read more →

PHARMAC knew of epilepsy drug change risks within some patients, but went ahead with switch

24 February 2021 - PHARMAC knew there were clinical reasons some epilepsy patients would not tolerate a change to their medicines.  ...

Read more →

Epilepsy drug deaths: Medsafe told PHARMAC it was 'not desirable' to switch brands

23 February 2021 - The medicines safety authority advised PHARMAC it was “not desirable” for patients to switch brands of ...

Read more →

Maker of epilepsy drug warned over quality control

23 February 2021 - The drug at the centre of an inquest into six epilepsy deaths was made at a plant ...

Read more →

Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes

22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...

Read more →

Supplier of expensive cystic fibrosis medication yet to apply for PHARMAC approval

17 February 2021 - Government drug-buying agency PHARMAC has revealed the supplier of expensive cystic fibrosis medicine Trikafta still hasn’t ...

Read more →